Literature DB >> 24442316

Cultured mycelium Cordyceps sinensis protects liver sinusoidal endothelial cells in acute liver injured mice.

Yuan Peng1, Qian Chen, Tao Yang, Yanyan Tao, Xiong Lu, Chenghai Liu.   

Abstract

Cultured mycelium Cordyceps sinensis (CMCS) was widely used for a variety of diseases including liver injury, the current study aims to investigate the protective effects of CMCS on liver sinusoidal endothelial cells (LSECs) in acute injury liver and related action mechanisms. The mice were injected intraperitoneally with lipopolysaccharide (LPS) and D-galactosamine (D-GalN). 39 male BABL/c mice were randomly divided into four groups: normal control, model control, CMCS treatment and 1,10-phenanthroline treatment groups. The Serum liver function parameters including alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were assayed with the commercial kit. The inflammation and scaffold structure in liver were stained with hematoxylin and eosin and silver staining respectively. The LSECs and sub-endothelial basement membrane were observed with the scanning and transmission electronic microscope. The protein expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in liver were analyzed with Western blotting. Expression of von Willebrand factor (vWF) was investigated with immunofluorescence staining. The lipid peroxidation indicators including antisuperoxideanion (ASAFR), hydroxyl free radical (·OH), superoxide dismutase (SOD), malondialdehyde and glutathione S-transferase (GST) were determined with kits, and matrix metalloproteinase-2 and 9 (MMP-2/9) activities in liver were analyzed with gelatin zymography and in situ fluorescent zymography respectively. The model mice had much higher serum levels of ALT and AST than the normal mice. Compared to that in the normal control, more severe liver inflammation and hepatocyte apoptosis, worse hepatic lipid peroxidation demonstrated by the increased ASAFR, ·OH and MDA, but decreased SOD and GST, increased MMP-2/9 activities and VCAM-1, ICAM-1 and vWF expressions, which revealed obvious LSEC injury and scaffold structure broken, were shown in the model control. Compared with the model group, CMCS and 1,10-phenanthroline significantly improved serum ALT/AST, attenuated hepatic inflammation and improved peroxidative injury in liver, decreased MMP-2/9 activities in liver tissue, improved integration of scaffold structure, and decreased protein expression of VCAM-1 and ICAM-1. CMCS could protect LSECs from injury and maintain the microvasculature integration in acute injured liver of mice induced by LPS/D-GalN. Its action mechanism was associated with the down-regulation of MMP-2/9 activities and inhibition of peroxidation in injured liver.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24442316      PMCID: PMC3933741          DOI: 10.1007/s11033-014-3031-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  11 in total

1.  Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver.

Authors:  K E Wack; M A Ross; V Zegarra; L R Sysko; S C Watkins; D B Stolz
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

2.  Antifibrotic effect of extracellular biopolymer from submerged mycelial cultures of Cordyceps militaris on liver fibrosis induced by bile duct ligation and scission in rats.

Authors:  J X Nan; E J Park; B K Yang; C H Song; G Ko; D H Sohn
Journal:  Arch Pharm Res       Date:  2001-08       Impact factor: 4.946

3.  Anti-inflammatory and related pharmacological activities of cultured mycelia and fruiting bodies of Cordyceps militaris.

Authors:  So-Young Won; Eun-Hee Park
Journal:  J Ethnopharmacol       Date:  2004-12-10       Impact factor: 4.360

4.  Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4.

Authors:  G L Su; R D Klein; A Aminlari; H Y Zhang; L Steinstraesser; W H Alarcon; D G Remick; S C Wang
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.

Authors:  B Wielockx; K Lannoy; S D Shapiro; T Itoh; S Itohara; J Vandekerckhove; C Libert
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

6.  Quantitative zymography: detection of picogram quantities of gelatinases.

Authors:  D E Kleiner; W G Stetler-Stevenson
Journal:  Anal Biochem       Date:  1994-05-01       Impact factor: 3.365

7.  Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration.

Authors:  D B Stolz; M A Ross; H M Salem; W M Mars; G K Michalopoulos; K Enomoto
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

8.  Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.

Authors:  W M Mars; T H Kim; D B Stolz; M L Liu; G K Michalopoulos
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

9.  Galactosamine-induced sensitization to the lethal effects of endotoxin.

Authors:  C Galanos; M A Freudenberg; W Reutter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

10.  Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation.

Authors:  D D SABATINI; K BENSCH; R J BARRNETT
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  9 in total

1.  Levistilide A inhibits angiogenesis in liver fibrosis via vascular endothelial growth factor signaling pathway.

Authors:  Zhi-Min Zhao; Hong-Liang Liu; Xin Sun; Tao Guo; Li Shen; Yan-Yan Tao; Cheng-Hai Liu
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-22

2.  Expression of ADAMTS13 in Normal and Abnormal Placentae and Its Potential Role in Angiogenesis and Placenta Development.

Authors:  Juan Xiao; Yun Feng; Xueyin Li; Wei Li; Lei Fan; Jing Liu; Xue Zeng; Kaiyue Chen; Xi Chen; Xiaoshui Zhou; X Long Zheng; Suhua Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-27       Impact factor: 8.311

Review 3.  ADAMTS13: more than a regulator of thrombosis.

Authors:  Yun Feng; Xueyin Li; Juan Xiao; Wei Li; Jing Liu; Xue Zeng; Xi Chen; Suhua Chen
Journal:  Int J Hematol       Date:  2016-10-01       Impact factor: 2.490

4.  Cultured Mycelium Cordyceps sinensis allevi¬ates CCl4-induced liver inflammation and fibrosis in mice by activating hepatic natural killer cells.

Authors:  Yuan Peng; Kai Huang; Li Shen; Yan-yan Tao; Cheng-hai Liu
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

5.  Cordyceps sinensis preserves intestinal mucosal barrier and may be an adjunct therapy in endotoxin-induced sepsis rat model: a pilot study.

Authors:  Guo-Sheng Gu; Jian-An Ren; Guan-Wei Li; Yu-Jie Yuan; Ning Li; Jie-Shou Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

6.  Ergosterol Is the Active Compound of Cultured Mycelium Cordyceps sinensis on Antiliver Fibrosis.

Authors:  Yuan Peng; Yanyan Tao; Qinglan Wang; Li Shen; Tao Yang; Zulong Liu; Chenghai Liu
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-15       Impact factor: 2.629

7.  Systematic revelation of the protective effect and mechanism of Cordycep sinensis on diethylnitrosamine-induced rat hepatocellular carcinoma with proteomics.

Authors:  Pei-Wen Wang; Yu-Chiang Hung; Wen-Tai Li; Chau-Ting Yeh; Tai-Long Pan
Journal:  Oncotarget       Date:  2016-09-13

8.  Acremonium terricola culture plays anti-inflammatory and antioxidant roles by modulating MAPK signaling pathways in rats with lipopolysaccharide-induced mastitis.

Authors:  Yang Li; Xin Jiang; Hongjian Xu; Jingyi Lv; Guangning Zhang; Xiujing Dou; Yonggen Zhang; Xiaoxiang Li
Journal:  Food Nutr Res       Date:  2020-11-13       Impact factor: 3.894

9.  Salvianolate Protects Hepatocytes from Oxidative Stress by Attenuating Mitochondrial Injury.

Authors:  Qiang Zhao; Yuan Peng; Kai Huang; Yang Lei; Hong-Liang Liu; Yan-Yan Tao; Cheng-Hai Liu
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-02       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.